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Poor-quality medicines are real threats to individuals and health systems 
worldwide. In developing countries, life-saving medicines, such as antibiotics, are the 
main target of counterfeiters. Substandard medicines are extremely prevalent due to 
poor manufacturing, distribution, and/or storage conditions. Data on the quality of 
medicines in Arab countries are very limited. This thesis is divided into two major parts. 
The first part investigated the quality of amoxicillin capsules and tablets sold in 
community pharmacies (CPs) in Riyadh, Saudi Arabia, as an indicator of the quality of 
medicines sold in them. It estimated the proportion of pharmacies that were selling 
poor-quality medicines relative to a predetermined threshold (20%). It also field tested 
an economical sampling method for classifying the CPs according to the quality of their 
medicines in order to help decision makers with resource allocation.  
Sampling was performed with the “mystery shopper” technique in 72 randomly 
selected CPs in Riyadh. The number of pharmacies for inclusion was calculated with 
Lot Quality Assurance Sampling (LQAS) method. The initial 1367 pharmacies were 
divided into two lots: chain and independent pharmacies (869 and 498, respectively). 
From each lot, 36 pharmacies were randomly selected, and 80 dosage units of a 
randomly selected amoxicillin brand were purchased from each selected pharmacy. If 
this brand was from more than one batch, the batches were considered different samples 
purchased from the same pharmacy. If samples from the same batch were purchased 
from different pharmacies, the samples were also considered different. The samples 
were checked for authenticity and analyzed for their drug content and content 
uniformity (CU) according to the United States Pharmacopeia (USP) by a validated 
high-performance liquid chromatographic (HPLC) method. If a sample from a 




pharmacy. If the number of failed pharmacies exceeded a predetermined decision value 
(three) in any lot, the lot was rejected and the proportion of pharmacies selling poor-
quality amoxicillin was classified as higher than the predetermined threshold. 
A total of 83 samples from 72 pharmacies were collected and analyzed (41 
samples from chain pharmacies and 42 from independent pharmacies). The samples 
were found to be authentic, but 9 were substandard because they failed the CU test, with 
6 of the 9 averaging less than 90% of the labeled content (the lowest was 80.7%). The 
content of the approved samples ranged from 90.6% to 104.2%. Certain batches passed 
the test in certain pharmacies and failed in others, indicating a possible degradation. The 
9 failed samples were purchased from 4 chain and 5 independent pharmacies. Both lots 
were rejected because the predetermined decision value was exceeded, indicating that 
more than 20% of the pharmacies in each lot were selling poor-quality amoxicillin. 
A problem existed with the quality of an essential drug in Riyadh’s CPs. 
Exposure to excessive temperature during distribution or storage has unfavorable 
consequences on the quality of medicines, particularly in hot climates. This could be 
one of the possible reasons behind the existence of substandard amoxicillin in Riyadh’s 
CPs. However, inefficient quality control at the manufacturing stage cannot be excluded.  
The second part of the thesis explored the conditions under which medicines 
were kept in a random sample of 181 CPs in Riyadh. The pharmacist in charge in each 
pharmacy was interviewed and observations about the quality of storage were recorded.  
The inspection revealed that in 9% of the CPs the readings of the existing room 
thermometers were more than 25 °C, and that 13% of the CPs lacked thermometers. 
Also in 33% of the CPs the readings of the refrigerator thermometers were outside the 
accepted range, and 7% of the CPs lacked refrigerator thermometers. About 15% of 




practice, neither before nor after taking up their current positions. Surprisingly, incorrect 
answers to simple questions about the system were frequently given by the informed 
pharmacists. Certain aspects of substandard storage conditions existed, in varying 
degrees, in significant percentages of pharmacies regardless of the pharmacists’ 
qualifications, experience, or awareness about the local regulations of community 
pharmacy practice.  
Stricter monitoring of the supply chain in Riyadh is necessary. More studies to 
monitor the quality of medicines and pharmacies are recommended, together with 
improvements in the education of pharmacists and distributors about the importance of 
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The Quality of Amoxicillin Capsules and Tablets 
in Community Pharmacies in Riyadh, Saudi 






 Introduction  
Background 
Poor-quality medicines could be counterfeit or substandard. Counterfeit 
medicines are “deliberately and fraudulently mislabeled with respect to identity and/or 
source. Counterfeiting can apply to both branded and generic products and counterfeit 
products may include products with the correct ingredients or with the wrong 
ingredients, without active ingredients, with insufficient active ingredient or with fake 
packaging”.[1] In contrast, substandard medicines are “genuine medicines produced by 
legitimate manufacturers that do not meet the quality specifications that the producer 
says they meet. For example, they may contain less (or more) active ingredient than 
written on the package. This may not be an intention to cheat, but may be due to 
problems with the manufacturing process”.[2] Degraded medicines may be considered 
substandard, although they were originally genuine and of good quality. These 
medicines show deterioration subsequent to their expiration date or deterioration due to 
exposure to harsh environmental conditions during distribution and/or storage.[3,4] 
The use of poor-quality medicines, especially counterfeits, may lead to a wide 
variety of health risks, including therapeutic failure, toxicity, bacterial resistance, and 
even death.[5] Moreover, the economic consequences of this situation are undesirable. 
Furthermore, people may lose their trust in health systems.[6] 
Counterfeit medicines have become a global issue because of the continuing 
growth in the market for these products and because of the consequences of their use.[7] 
Although developing countries are the principal target of counterfeiters,[8,9] developed 
countries face many of the same risks.[9,10] Sadly, essential medicines (e.g., 




 countries.[11] For example, counterfeit anthelminthics have been reported in 
Cambodia,[12] counterfeit antimalarials in several African countries,[13] and substandard 
antibiotics in India.[14] One study reported substandard amoxicillin in four Arab 
countries (Lebanon, Jordan, Egypt and Saudi Arabia).[15] In that study, the content of 
amoxicillin in capsules and suspensions was investigated, although the number of 
samples collected from each country and the methodology of sample collection were not 
specified in detail. However, the authors concluded that the prevalence of substandard 
amoxicillin products in these Arab countries was high. 
Studies with sound and reproducible methodology on the quality of medicines in 
developing countries are very limited. Convenience sampling is widely used for this 
purpose, even though bias is clearly introduced because usually only accessible 
pharmacies or outlets are selected. Formal random sampling generally requires a larger 
sample, longer surveying time, and more resources. For these reasons, Lot Quality 
Assurance Sampling (LQAS) has been proposed as an economical technique to survey 
the quality of medicines sold in community pharmacies.[3] LQAS was developed in the 
1920s to assess the quality of industrial products by inspecting random samples.[16] It 
was later adapted and successfully used in a variety of health care surveys and 
settings,[17] such as the rapid assessment of the prevalence of active trachoma,[18] 
assessing the prevalence of acute malnutrition,[19] evaluation of the polio eradication 
initiative,[20] and identifying inadequately performing areas for health services.[21] 
However, it was not used for surveying the quality of medicines in the supply chain. 
Because LQAS uses a relatively small sample, it cannot determine the prevalence (rate) 
of outlets that sell low-quality medicines, but rather provides a way to classify the rate 




 helpful to enable decision makers to properly allocate and distribute resources among 
various supervisory areas, and also provides an indication as to whether or not larger-
scale, randomized surveys are required. 
In Saudi Arabia antibiotics are very commonly prescribed.[22–29] Self-medication 
is a common practice, and several prescription medicines, including antibiotics, can be 
purchased without a prescription despite the government’s regulations.[22,23] Drug 
regulation in this country was originally the duty of the Ministry of Health (MOH), 
which established a strict system for pharmaceutical facilities and products. That system 
included detailed standards intended to ensure the best quality of medicines at all stages, 
from manufacturing to dispensing, if applied appropriately.[30] Recently, the Saudi Food 
and Drug Authority (SFDA) was established as an independent corporate body that 
reports directly to the President of the Council of Ministers. It is responsible for 
ensuring the safety of food and drugs for human and veterinary use and the safety of 
biological and chemical substances and medical devices. The establishment of the 
SFDA is still in its initial stage. By the end of this stage, all matters relating to drug 
regulation will be delegated to this authority.[31]   
Amoxicillin is widely used because it is included in the list of essential drugs 
issued by the World Health Organization (WHO).[32] It is also considered an essential 
drug in primary health care in Saudi Arabia.[33] It is also among the most widely 
counterfeited medicines in developing countries.[9,11] Substandard amoxicillin has 
already been identified in Saudi Arabia in one study.[15] Furthermore, amoxicillin 
products, including suspensions and capsules, are sensitive to heat and may degrade 




 indicator of the quality of medicines in the supply chain in Saudi Arabia, where high 
temperatures are common.  
 
Objectives 
One of the aims of this study is to field test an economical, easily reproducible 
and statistically valid method for monitoring the quality of medicines in community 
pharmacies in Riyadh, the capital of Saudi Arabia. This method estimates the proportion 
of pharmacies that sell poor-quality medicines relative to a predefined threshold. A 
finding that this threshold is exceeded is interpreted to indicate a significant problem 
that requires intervention by the SFDA. In addition, the results obtained with this 
method can help decision makers classify the quality of the provision of medicines and 
can therefore help with the allocation of resources. This method could be the first step in 
determining whether large-scale, randomized surveys are required and can serve as a 
baseline for future studies using the same sampling methodology. The study also 
provides reliable data about the quality of amoxicillin capsules and tablets sold in 
community pharmacies in Riyadh, as a model of an essential drug and a medicine 
quality indicator.  
 
The Null Hypothesis 
Based on a review of the literature on the quality of amoxicillin in developing 
countries[9,11,15,35,36] and considering the possible differences between these countries 
and Saudi Arabia (e.g., the economy and the regulatory environment), the null 
hypothesis was formulated that > 20% of the community pharmacies in Riyadh, either 




 Methods  
The design of this study and the sampling technique were approved by the 
Ethical Committee of Kanazawa University, as well as by the SFDA. Samples were 
collected between September 21 and October 3, 2010, in the city of Riyadh. The 
samples were shipped to Kanazawa University, Japan, in temperature-preserving 
containers on a secure courier after obtaining the necessary clearance documents from 
the SFDA and the Japanese Customs Department. The analysis was performed in the 
Department of Drug Management and Policy at Kanazawa University between May 25, 
2011 and February 7, 2012 before the expiration dates of all samples, which were kept 
in their original packaging under controlled room temperature of 22 °C until analysis.  
Because two levels of sampling (the selection of pharmacies and the selection of 
amoxicillin brands) were included in this study and to avoid any confusion, the term 
“sample” was used to indicate amoxicillin samples and the term “subject” for the 
pharmacies selected for the study. The term “target pharmacy” refers to pharmacies that 
sell poor-quality amoxicillin. 
 
Selection of Pharmacies 
A list of registered community pharmacies and their addresses in Riyadh was 
obtained from the SFDA by July 2010 (1367 pharmacies). The pharmacies were then 
divided into two lots, chain and independent (869 and 498 pharmacies, respectively, 
with a total number of 82 chains). These two lots represented the sampling frames. A 
pharmacy was considered independent if it belonged to a group of ≤ 3 pharmacies, 
whereas a chain pharmacy was considered to belong to a group of ≥ 4 pharmacies.[37] 




 medicines in pharmacies differs according to an economy of scale and to check the 
possible impact of the supply chain on the quality of medicines. 
The required number of pharmacies required for the investigation was calculated 
according to the Lot Quality Assurance Sampling (LQAS) technique. LQAS employs a 
binomial formula (Figure 1.1) that requires predefined upper and lower prevalence (or 
rate) thresholds for the target subjects in a lot to classify the lot as a high- or a low-
prevalence lot in terms of the proportion of target subjects. The formula must be applied 
for both thresholds to calculate the probability of correctly classifying a lot at both 
thresholds (sensitivity and specificity) and the associated alpha and beta errors (chances 
or risks) of misclassification. Probability (or error) calculation is performed for all 
possible combinations of the numbers of subjects (target and non-target), increasing the 
P = the probability calculated at p. 
x = decision rule (i.e., number of target 
pharmacies out of n). 
n = required number of subject 
pharmacies. 
p = the predefined prevalence (rate) 
threshold of target pharmacies. 
q = the predefined prevalence (rate) 
threshold of non-target pharmacies 
(i.e., 1 ‒ p). 
Figure 1.1.  LQAS equations. 
S = predefined number of target 
pharmacies out of N (i.e., p × N). 




Γ(a) = the gamma function of a. 
The binomial formula The hypergeometric 
formula 





 total number of subjects by 1 after each round of combinations of each total, until the 
minimum number of total subjects coinciding with the lowest possible combination of 
actual errors (≤ the predefined errors) and their sum is reached at both thresholds 
simultaneously. At this latter combination, the total number of subjects represents the 
number of subjects required for the study, and the number of target subjects (associated 
with the condition being studied) represents the decision rule. If this decision rule is 
exceeded, the lot is classified as a high-prevalence lot relative to the condition under 
study. Otherwise, the lot is classified as a low-prevalence lot. The probabilities (or 
errors) obtained at each combination must be cumulative (the sum of the current and the 
previous values in the same round of combinations). Finally, the condition under study 
determines whether the lot is accepted or rejected if it is classified as either high- or 
low-prevalence. A consumer risk occurs when a lot is misclassified as “good” (i.e., 
misclassified as having a high rate of good subjects or a low rate of bad subjects), and a 
provider risk occurs when a lot is misclassified as “bad” (i.e., misclassified as having a 
high rate of bad subjects or a low rate of good subjects). The classification of an error 
(alpha or beta) as either a consumer risk or a provider risk depends on the formulation 
of the null hypothesis and, consequently, on the definitions of the thresholds.  
In this study, the target subjects are the pharmacies that sell poor-quality 
amoxicillin. Ideally, no pharmacy in any lot would sell poor-quality medicines. 
However, studies from developing countries have reported a variety of rates of 
counterfeit and substandard antimicrobials ranging from 2.8% to more than 50%, with 
the majority of the rates within a range of 30‒40%.[9] In addition, a variable content of 
amoxicillin, ranging from 0% to 85%, was reported in several studies that documented 




 and regulatory environment in Saudi Arabia, the following upper and lower prevalence 
thresholds were adopted in this study: a lot with a rate of target pharmacies > 20% was 
classified as a high-prevalence lot (and hence rejected), whereas a lot with a rate of 
target pharmacies ≤ 5% was classified as a low-prevalence lot. This classification is not 
ideal. However, it is acceptable because it requires minimal resources relative to those 
needed to improve high-prevalence lots. The LQAS decision rule only classifies the rate 
as either > the predefined upper threshold or ≤ the predefined lower threshold. It is not 
sensitive to rates between these thresholds. The consumer risk (alpha error) was 
specified as a predetermined value of ≤ 0.05. This value represents the probability of 
rejecting a true null hypothesis (classifying a high-prevalence lot as low-prevalence). 
The provider risk (beta error) was specified as a predetermined value of ≤ 0.10. This 
value represents the probability of failing to reject a false null hypothesis (classifying a 
low-prevalence lot as high-prevalence).  
The binomial LQAS formula is preferred if the population size is either 
unknown or very large.[38] However, the hypergeometric model of LQAS was used in 
this study for sample size and decision rule calculation (Figure 1.1) because each 
subject pharmacy was included only once and because the population size of 
pharmacies in each lot was known and relatively small. These characteristics allow the 
actual errors to be calculated more accurately.[39,40] In this model, the gamma function is 
used for the calculation of factorials of fractions (Figure 1.1). The minimum number of 
subject pharmacies that produced the lowest combination of errors at both thresholds 
was 36 pharmacies from each lot, with 3 as the value for the decision rule. Table 1.1 
shows a part of the calculation process. If the number of pharmacies that sell poor-




 high prevalence of pharmacies that sell poor-quality amoxicillin and will therefore be 
rejected. This outcome implies that more resources must be directed toward the lot to 
investigate and correct the situation. Otherwise, the lot will be classified as a low-
prevalence lot, one requiring fewer resources. A calculator that uses this calculation 

















For chain pharmacies (N = 869) when n = 36  
0 0.9997 0.0003 0.1517 0.8483 0.8486 
1 0.9972 0.0028 0.4519 0.5481 0.5509 
2 0.9855 0.0145 0.7336 0.2664 0.2809 
3 0.9512 0.0488 0.9006 0.0994 0.1482 
4 0.8783 0.1217 0.9708 0.0292 0.1509 
5 0.7591 0.2409 0.9931 0.0069 0.2478 
6 0.6027 0.3973 0.9987 0.0013 0.3986 
For independent pharmacies (N = 498) when n = 36 
0 0.9998 0.0002 0.1471 0.8529 0.8531 
1 0.9975 0.0025 0.4481 0.5519 0.5544 
2 0.9866 0.0134 0.7348 0.2652 0.2786 
3 0.9538 0.0462 0.9039 0.0961 0.1423 
4 0.8823 0.1177 0.9732 0.0268 0.1445 
5 0.7633 0.2367 0.9941 0.0059 0.2426 
6 0.6054 0.3946 0.9990 0.0010 0.3956 
The first 7 rows of probability combinations are shown. x = decision rule, N = population 
size, n = required number of subject pharmacies, sensitivity = 1 – cumulative alpha error, 
Beta error = 1 – cumulative specificity. 
Minimum accepted errors (and their sum) occur when x = 3 in the round of n when n = 36 
for each lot (shaded areas of the table). This indicates that the smallest required number of 
subject pharmacies is 36. If the calculation continues, other good combinations will be 
obtained. However, this would require additional pharmacies. At n = 36, the finding of ≤ 
3 target pharmacies indicates that their rate in the corresponding lot is ≤ 5%. However, 
this rate is acceptable according to the predefined thresholds in this study. The finding of 
> 3 target pharmacies means that their rate is > 20%. Because this rate is unacceptable, 
the corresponding lot (i.e., category of pharmacy) is rejected.  
 
Table 1.1.  Part of the calculation process for deciding the required number of 





 It is worth mentioning that formal random sampling would have required a 4- to 
5-fold larger number of pharmacies in each category, and therefore the resources 
required would have been 4- to 5-fold greater. This represents a significant advantage 
for LQAS, especially in developing countries. 
An initial alphabetical list of pharmacies in each lot was created, and each 
pharmacy was given a special code. Each coded list was then scrambled, and 45 (36+9) 
pharmacies were randomly selected from each list by one of the co-investigators with 
MS Excel 2010 (Microsoft Co., USA). The additional 9 pharmacies represented a 
reserve for an estimated dropout rate of 25%. A pharmacy could be excluded, and 
replaced by one from the reserve list, for any of the following reasons: (a) the pharmacy 
was closed on the second visit, (b) the pharmacy was out of business, (c) the pharmacy 
did not have a sufficient number of amoxicillin dosage units (80 units from the available 
brands), or (d) the pharmacy refused to sell amoxicillin without a prescription. The 
randomly selected pharmacies from both lots were grouped by districts to facilitate 
sample collection. The same district distribution used in the list of pharmacies provided 
by the SFDA, in which the total number of districts was 114, was followed in this study 
(Annex 1.1). Sampling continued until samples had been purchased from 36 pharmacies 
in each lot. 
 
Amoxicillin Sampling 
The “mystery shopper” technique was used in the purchasing of the samples 
because an unwanted change in the seller’s behavior might result if the identity of the 
investigator was known to the seller.[42,43] Such behavioral changes might include non-




 a Saudi Arabian citizen, played the role of the mystery shopper and was accompanied 
by two co-investigators in the field. This sampling technique was field tested prior to 
actual sampling and was standardized using the same scenario in each pharmacy. In this 
scenario, the sampler asked the seller to show him all brands of amoxicillin capsules 
and tablets available in 4‒5 packs (80 dosage units) because one of the sampler’s friends 
wanted the medicine. The sampler also told the seller that he would call his friend to tell 
him about the available brands and strengths to allow the friend to select the product to 
be purchased. Then, all brands and strengths that were available in sufficient quantities 
were numbered in a list reflecting the order in which the seller presented them, 
excluding any clavulanate-containing products. Each strength of a given brand was 
treated as a separate brand. A mobile telephone operated by Windows Mobile was used 
to rapidly generate a random number between 1 and the highest number on the list from 
Excel Mobile. This procedure was conducted while the sampler appeared to be making 
the call. In this way, one brand of amoxicillin capsules or tablets was randomly 
purchased from each randomly selected pharmacy. 
If the 80 dosage units were from more than one batch, they were considered 
different samples purchased from the same pharmacy (i.e., a sample was a number of 
dosage units of the same batch purchased from a single pharmacy). Samples from the 
same batch of the same brand purchased from different pharmacies were considered 
different samples. If a sample from a pharmacy was found to be of poor quality, the 
pharmacy was considered a failed pharmacy.  
After sampling from each pharmacy, the sampler and one of the co-investigators 
immediately completed the sampling form outside the pharmacy. The contents of the 




 Samples were immediately placed in a temperature-preserving container. The car air 
conditioner was operating effectively during all sampling trips. Amoxicillin brands were 
coded with the letters A–P.  
 
Amoxicillin Authenticity Investigations 
Dosage units, strips, boxes, and package inserts of all samples were visually 
inspected. Parts of all those items were sent to the corresponding manufacturers for 
authenticity confirmation including a special form (Annex 1.3). The SFDA was 
contacted to verify the registration status of the products. 
 
Analysis and Materials 
The content uniformity test was performed using high-performance liquid 
chromatography (HPLC) according to the 34th edition of the United States 
Pharmacy code and type Batch number 
Sample code Manufacture date 
Sampling date Expiration date 
Package condition and type Price 
Trade name Pharmacy name 
Manufacturer’s name Pharmacy type 
Manufacturer’s country Pharmacy address 
Distributor in Saudi Arabia Pharmacy general neatness 
Dosage form Exposure of shelves to sunlight 
Strength Quality of air-conditioning 
Package size Pharmacist nationality and qualification 
Registration number in Saudi Arabia Willingness of selling unregistered drugs  
 





 Pharmacopeia (USP 34).[44,45] The only difference was using a shorter HPLC column 
(15 cm instead of 25 cm). However, the use of the shorter column would not affect the 
results as long as the method was validated. All samples were submitted to the first 
stage of the test, which involved 10 dosage units of each sample. Failed samples were 
challenged at the second stage, which involved 20 additional units. However, samples 
that were outside the deviation range of the first stage were treated as permanently 
failed without the need for a second stage of testing, as indicated by the USP. For every 
sample the amoxicillin content, which should range from 90.0%‒120.0% for capsules 
and 90.0%‒110.0% for tablets, according to the USP, was calculated by averaging the 
content of the dosage units analyzed in the content uniformity test. 
All chemicals used were of analytical grade. Acetonitrile, potassium dihydrogen 
phosphate, and potassium hydroxide were purchased from Nakalai Tesque (Kyoto, 
Japan). The diluent was prepared by accurately dissolving 13.6 g of potassium 
dihydrogen phosphate in 2000 mL of distilled water adjusted with potassium hydroxide 
solution to a pH of 5. The mobile phase was prepared by mixing acetonitrile and the 
diluent in a ratio of 4:96. 
The HPLC system consisted of the following components from JASCO (Tokyo, 
Japan): a pump (PU–2080 Plus), a UV detector (UV–2075 Plus) set at 230 nm, a 
column thermostat (CO–1560), a degasser (DG–980‒50), a system controller (LC–Net 
II/ADC), and an autosampler (AS–950). The system was equipped with a Shim‒pack 
CLC–ODS (M) column—a 4.6 × 150 mm column filled with 70% methanol from 
Shimadzu (Kyoto, Japan). The system was linked with a computer running ChromNav 
software from JASCO (Tokyo, Japan) for interpreting the results and plotting curves 




 Standard amoxicillin, conforming to the USP Reference Standard (USPRS), was 
obtained from the Department of Medical Sciences, Bureau of Drug and Narcotic, 
Ministry of Public Health, Thailand. Standard cefadroxil, from Sigma (St Louis, MO, 
USA), was used as the internal standard. 
Peaks of amoxicillin and cefadroxil were observed at 6 and 8 minutes, 
respectively, with a flow rate of 0.6 mL/min (Figure 1.2). The linearity of the standard 
amoxicillin/diluent solution was maintained between 0.025 and 0.5 mg/mL and the 
analytical range was 0.05‒0.4 mg/mL (Figure 1.3). The linearity of the standard 
cefadroxil/diluent solution was maintained between 0.025 and 0.2 mg/mL and the 
analytical range was 0.05‒0.15 mg/mL (Figure 1.4). 
A daily calibration curve was produced by 3 concentrations of standard 
amoxicillin (0.05, 0.10, and 0.2 mg/mL) prepared from a freshly prepared stock solution 
of 1 mg/mL (on anhydrous base). A daily stock solution of standard cefadroxil (0.2 
mg/mL on anhydrous base) was freshly prepared and was added to all sample and 
Figure 1.2.   Retention times of amoxicillin and cefadroxil peaks (6 and 8 minutes, 





 calibration solutions to obtain a final concentration of 0.1 mg/mL in each solution 
(Figure 1.5). 
The samples were analyzed in the order of their expiration dates. Each capsule 
was completely emptied, and the powder was dissolved in 200 or 400 mL of the diluent 
according to the capsule strength (250 or 500 mg, respectively). The flask was shaken 
  
Figure 1.3. Linearity of amoxicillin solution, using cefadroxil as an internal standard. 
  
Figure 1.4.  Linearity of cefadroxil solution. 
y = 2.2932x - 0.0015 







 vigorously 20 times and sonicated for 20 minutes. All tablets were of 500 mg strength. 
Each tablet was ground to fine powder in a mortar and was then dissolved in 400 mL of 
the diluent, shaken vigorously 20 times, sonicated for 5 minutes, and stirred for 30 
minutes. Part of the solution was then centrifuged and the supernatant was used for 
analysis. The necessary dilution was then made for each sample solution with the 
diluent and the internal standard solution so that the theoretical concentration of 
amoxicillin would fall within the analytical range (Figure 1.6). 
The final sample and calibration solutions were filtered through 0.2 µm Minisart 
RC 4 syringe filters from Sartorius Stedim (Dublin, Ireland). All solutions were used 
within 6 hours of preparation and analyzed in triplicate. 
For method validation, Intra- and inter-day precision were determined by 
analyzing three solutions of standard amoxicillin of different concentrations (0.06, 0.12, 
Figure 1.5.  Daily preparation of amoxicillin calibration curve using cefadroxil as an 





 and 0.18 mg/mL) over a period of three days. An accuracy test for the method was 
performed by applying the standard-addition (spiking) recovery technique. Using this 
technique, one dosage unit from each strength of each brand of amoxicillin tablets and 
capsules was analyzed for amoxicillin content. Standard amoxicillin was then added to 
three aliquots of the pre-analyzed solution in three different concentrations (0.025, 0.05, 
0.075 mg/mL), and the solutions were analyzed again to determine the total amoxicillin 
concentration. Finally, the recovered amount of added amoxicillin was calculated. This 
test was repeated three times using three dosage units, and the average recovery was 
calculated (Figure 1.7). All values of standard deviation, relative standard deviation, and 
relative error for both precision and accuracy were less than 2%, based on a 95% 
confidence interval. These values were considered satisfactory. 
 





   
  





 Results  
Eighty-five pharmacies (43 chain and 42 independent) were visited during the 
sampling period in 53 of the 114 districts of Riyadh. The dropout was 7 and 6 for chain 
and independent pharmacies, respectively. Dropouts occurred for reasons a, b, and c, 
mentioned above (5, 4, and 4 pharmacies, respectively). No major differences for 
dropping out were found between the independent and chain lots. No pharmacies were 
excluded because they refused to sell amoxicillin without a prescription.  
In all, 83 samples were collected from 72 randomly selected subject pharmacies. 
Of these samples, 41 were collected from chain pharmacies and 42 from independent 
pharmacies (Table 1.3 and Annex 1.4). Six samples (7%) were tablets, two of which 
were purchased from chain pharmacies and the rest from independent pharmacies. The 
remaining samples were all capsules. Twenty-eight samples (35%) were locally 
manufactured, 47 (57%) were imported from other Arab countries, and 7 (8%) were 
imported from Europe. The samples included 16 brands produced by 10 manufacturers. 
These samples represented all the manufacturers registered by the SFDA at the time of 
sampling.  
Visual inspection revealed that all the samples were neatly packaged in boxes 
containing push-through strips and a pamphlet. All samples and packaging of each 
brand were identical and included the registration code in Saudi Arabia, as well as the 
price and the name of the distributor. The price was identical for each sample of the 
same brand. The batch numbers, manufacturing dates and expiration dates on the boxes 
and strips were found to match. Authenticity was confirmed by all manufacturers, seven 




 attached questionnaire were not complete. Finally, the registration status of each 
product and manufacturer was confirmed by the SFDA. 
One sample was outside the deviation range of the first stage of the content 
uniformity test and failed the test for this reason. Fourteen samples failed the first-stage 
acceptance value (AV = 15%). Eight of these samples failed the second stage and hence 




Number of samplesa 
Number of 
batchesb 






Ac 4 4 8 3 
Bc 4 3 7 5 
Cd 2 0 2 2 
Dd 3 4 7 6 
Ed 3 7 10 6 
Fe 1 0 1 1 
Ge 2 0 2 2 
Hd 0 1 1 1 
Id 6 1 7 5 
Jc 1 5 6 4 
Kd 3 2 5 3 
Le 0 4 4 3 
Md 4 6 10 10 
Nc 2 0 2 2 
Oc 5 1 6 2 
Pd 1 4 5 3 
Total 41 42 83 57 
a A sample is a batch purchased from a single pharmacy. If the same batch is purchased at 
another pharmacy, it is considered as a different sample. Different batches of the same 
brand purchased from the same pharmacy are also considered as different samples. 
b The number of batches of the corresponding brand purchased from all pharmacies 
without repetition. 
c Manufactured in Saudi Arabia. 
d Imported from other Arab countries. 





 failed the test. In all, a total of 9 samples (11%) failed the test. All of these samples 
were capsules. The failed samples were purchased from 9 pharmacies (4 chain and 5 
independent) that belonged to different chains or owners and included five brands from 
four manufacturers (Figure 1.8). However, no sample for brand C was purchased from 
any independent pharmacy. The content of 6 of the failed samples was below 90%. The 
lowest content was 80.7%. The content of the approved samples ranged from 90.6% to 
104.2% (Figure 1.9). Interestingly, certain batches of certain brands passed the content 
and/or content uniformity tests in some pharmacies, but failed in others (Table 1.4). A 
summary of the sample analyses can be found in Annex 1.5. 
The number of pharmacies that sold poor-quality amoxicillin in each lot of 
pharmacies was greater than the decision value of 3. For this reason, both the chain and 
independent lots were rejected. As a result, the null hypothesis failed to be rejected, and 
both lots were classified as high-prevalence lots. This result shows that more than 20% 
of the pharmacies in each lot sell poor-quality amoxicillin, an outcome suggestive of a 
significant problem with important public health implications. 
The following observations were recorded while visiting the pharmacies for 
sampling. The air-conditioning was totally unsatisfactory in one independent pharmacy 
and one medicine shelf was exposed to direct sunlight in another independent pharmacy. 
Neatness and cleanliness was satisfactory in all pharmacies. Surprisingly a prescription 
was not requested by all pharmacies, and instructions about the use of amoxicillin were 
not offered by all of them. It was also noted that in some pharmacies there were certain 
signs stating clearly that prescription-only medicines cannot be sold without 




 independent pharmacies. All pharmacists in the visited pharmacies were non-Saudis. 
Tabulated pharmacy information can be found in Annex 1.6. 
 










content (%) Pharmacy type No. Status 
B 
1 Failed 15.66 92.36 Independent 
2 Passed 07.35 94.74 Independent 
D 
1 Failed 19.92 86.81 Independent 
2 Passed 14.20 91.11 Independent 
O 
1 Failed 27.06 84.43 Independent 
2 Passed 05.57 95.96 Chain 
3 Passed 08.46 95.38 Chain 
4 Passed 13.21 93.57 Chain 
P 
1 Failed 15.08 90.66 Independent 
2 Failed 17.24 91.89 Independent 
3 Passed 08.26 95.41 Independent 
a
 Acceptance value must be ≤ 15%. 
 










 Discussion  
Although counterfeit products were not identified by this survey, substandard 
samples represented 11% of the total samples. This result may indicate a high 
prevalence of substandard amoxicillin products in community pharmacies in Riyadh. 
This finding is consistent with the findings of Kyriacos et al.,[15] although the sample 
size for the amoxicillin products purchased in Saudi Arabia was not specified in that 
study. It was also found in this study, as in that previous study, that all European 
samples passed the quality tests used. In addition, all tablet forms passed the quality 
tests. However, it is difficult to perform a valid comparison due to the small percentage 
of European samples (8%). Similarly, it cannot be stated conclusively that tablet forms 
are more stable than capsules because of the small percentage of tablets (7%). However, 
small percentages of tablet forms and European products were expected to be found in 
Saudi Arabia because the sales of these items during the second quarter of 2009, 
expressed as percentages of the total sale of amoxicillin capsules and tablets, were 
3.96% and 4.32%, respectively, according to the SFDA (personal communication). 
In this study it was also found that certain batches passed the content and/or 
content uniformity test in certain pharmacies and failed in others. This result suggests 
the occurrence of degraded products that were originally of good quality and suggests 
that degradation may have occurred due to poor storage and/or distribution conditions 
(Table 1.4). In general, Riyadh climate is arid with extreme increase of temperature in 
summer and decrease in winter. The samples were collected during a very hot season, 
when the outside temperature in Riyadh during the daytime reached approximately 
45 °C. Poor temperature control in the distributors’ facilities, such as warehouses and 




 although the air conditioning in the vast majority of the visited pharmacies was 
satisfactory during sampling, the possibility that the air conditioners failed or were not 
used in certain pharmacies at certain times cannot be excluded. In addition, possible 
poor quality control practices during the manufacturing of several other batches that 
totally failed cannot be excluded. This hypothesis is supported by the appearance of the 
powder of the capsules of several failed samples from a certain manufacturer. The 
powder was in the form of a hard mass that appeared to have formed when the sample 
became dry after having been in a hygroscopic state. This observation suggests that the 
problem was caused by poor packaging.  
The average content of the active ingredient in the failed samples was greater 
than 80%. This value contrasts with the low values found by Kyriacos et al. (59%).[15] A 
lower content of amoxicillin was also reported in another study in Nigeria. Only 24% of 
the amount shown on the label was found in that study.[35] Counterfeit or substandard 
amoxicillin was found in several countries. The reported amoxicillin content of these 
products varied, reaching zero in certain cases.[9] However, the results of this study 
seem consistent with the findings of a study conducted in Indonesia, where 20% of the 
amoxicillin tablets analyzed contained an amount of active ingredient slightly below the 
lower acceptable range according to the British Pharmacopeia (BP).[36] It should be 
noted that in this study, based on the content range of 92.5‒110% specified in the BP 
2012,[46] two more samples would have failed the content test (one sample from each 
lot). 
Nevertheless, the existence of a substandard essential medicine in community 
pharmacies in Riyadh, a capital city where inspection and monitoring are expected to be 




 ingredient would be prevalent in other cities or in remote areas of the country due to less 
strict monitoring and control and less satisfactory storage and/or distribution conditions.  
In addition, the problem appears to exist regardless of the economy of scale of 
pharmacies (chain or independent). The number of pharmacies selling poor-quality 
amoxicillin exceeded the decision value in both lots. For this reason, the lots were both 
considered to have high prevalence rates. This finding suggests that possible 
intervention strategies should target both types of community pharmacies, regardless of 
the anticipated quality of the service provided. 
The LQAS technique with a mystery shopper provided a readily reproducible 
and statistically valid sample collection method that requires a small sample. The use of 
this method is recommend for future monitoring by the SFDA or other investigators in 
Saudi Arabia. It is also recommended that that this methodology be followed as a model 
for investigating the quality of other medicines and pharmacies in Saudi Arabia, and 
probably other countries. This methodology can be also used as a follow-up technique 
to monitor the changes that may occur following suitable intervention. However, the 
medicine selected as an indicator of the quality of medicines may need to be changed 
according to the geographical area surveyed. In this study, amoxicillin was selected 
because it is widely used, widely counterfeited, and heat-labile (Riyadh is very hot 
during summer), and also because substandard amoxicillin was reported in Saudi Arabia 
in one study. 
In theory, LQAS sampling can be terminated if the decision rule is exceeded at 
an early stage of the survey. In this way, the target can be achieved with minimal cost 
and time. The termination of sampling at an early stage was not possible in this study, 




 in the field. In addition, the results of the survey could indicate whether large-scale, 
randomized surveys are required for further investigation of the problem. 
 
Limitations 
The following limitations may have affected the extent to which the results of 
this study can be generalized. First, only capsule and tablet dosage forms were sampled 
because suspension bottles are bulky and may break easily during shipping to Japan, 
where the analysis was performed. Therefore, the findings of this study cannot be 
expanded to other amoxicillin dosage forms.  
Second, it was not possible to collect samples of a single batch from each 
pharmacy because asking the seller about batches would have revealed that the 
pharmacy was under investigation. As a result, more than one sample was obtained 
from several pharmacies. However, if a sample from a given pharmacy failed in the 
analysis, then the pharmacy failed in the lot, regardless of the quality of the other 
sample(s) purchased from the same pharmacy. 
Third, samples were analyzed in the order of their expiration dates by the 
investigator, who was not blinded as to the samples being analyzed, but was blinded as 
to the pharmacies from which the sample(s) were obtained. Unintentional expectation 
bias might have been introduced because the investigator is a Saudi Arabian clinical 
pharmacist. However, this factor is unlikely to have affected the results of the study 
because several samples failed from certain pharmacies but passed from others and 
because the samples were repeatedly measured with a validated method.  
Fourth, only content and content uniformity tests were applied in this study. The 




 Therefore, “quality” in this study refers only to the acceptable amount and uniformity of 
the active ingredient in terms of the range specified by the USP. If the amount of active 
ingredient was outside the range, it was concluded that the sample failed, irrespective of 
other quality parameters. Moreover, degradation products were not analyzed for 
characterizing the failed samples as substandard or degraded. However, some samples 
passed the tests while other samples from the same batch but purchased from different 
pharmacies failed them, a finding suggestive of the degradation issues. There are several 
methods that can differentiate between degraded and originally substandard 
amoxicillin.[47,48] These methods may be used in future studies. 
Finally, because LQAS requires smaller sample sizes, this study does not 
provide an accurate estimate of the prevalence of poor-quality amoxicillin or of poor-
quality pharmacies. However, the objective was not to provide an accurate prevalence 
rate but to classify reliably whether the prevalence rate of poor-quality medicines or 
pharmacies was above or below the threshold defined in the null hypothesis. With a 
larger sample size, which requires more resources for sampling and analysis, stratified 
random sampling is still the best method for accurate prevalence estimation. However, 
the LQAS method could help decision makers with limited resources to classify health 
system services, such as the provision of medicines in community pharmacies, 
according to a predetermined threshold. The results of such analyses could help decision 
makers allocate the resources intended for improvement accordingly even if the number 





 Conclusions   
Although this study has several limitations, it can be concluded from its results 
that deficiencies in the quality control of the supply chain and/or storage exist in Riyadh, 
either at the level of wholesalers or pharmacies, in addition to possible manufacturing 
defects for certain brands of amoxicillin. Based on this conclusion, the SFDA is advised 
to perform routine monitoring of wholesalers and pharmacy storage facilities, 
distribution facilities, and environmental settings inside pharmacies (e.g., temperature, 
humidity and exposure to sunlight). In addition, distributors, pharmacy owners, and 
pharmacists should be educated about the possible consequences of failing to adhere to 
appropriate distribution and storage conditions for the provision of medicines. 
Quality inspection at the level of manufacturing must also be strengthened, and 
optimal conditions must be maintained during the clearance of imported medicines.  
Finally, it is strongly recommend that additional research similar to the current 
study be conducted to investigate the quality of provision for other medicines in Riyadh 
and other areas of Saudi Arabia, as well as the quality of community pharmacies in 
terms of their adherence to the optimal conditions for keeping and selling medicines and 
the services provided by these pharmacies. Larger-scale randomized surveys would be 
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Annex 1.1.  Maps 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Adherence of Community Pharmacies 
in Riyadh, Saudi Arabia, to Optimal 






 Introduction  
Background 
The quality of medicine is a global issue due to the ever increasing prevalence of 
counterfeit medicines worldwide.[1,2] Substandard medicines produced by legitimate 
manufacturers represent another threat as they may not contain the correct amount of 
active ingredients or may have manufacturing defects that alter their efficacy or make 
them dangerous for use.[3,4] On the other hand, even good quality medicines could be 
risky if they degrade due to poor storage or distribution conditions.[5,6] 
This study is based on the results of the previous study (Chapter 1), which 
adopted the lot quality assurance sampling (LQAS) as a surveying technique to 
investigate the community pharmacies in Riyadh, Saudi Arabia, regarding the quality of 
medicines they sell.[7] It was conducted during a very hot season and amoxicillin was 
selected as an indicator of the quality of medicines in those pharmacies. The study 
reported substandard amoxicillin products in 13% of the randomly selected pharmacies. 
Although all samples were found to be authentic and the amount of the active ingredient 
was not dramatically low, it was below the lower limit of 90.0% according to the United 
States Pharmacopeia (USP), with the lowest amount being 80.7%. Manufacturing 
defects could not be ruled out but it was also suggested that degradation may have 
occurred to some samples due to poor storage or distribution conditions. That was 
supported by the finding that certain samples passed the quality test while other samples 
from the same batch, but purchased from other pharmacies, failed it.  
Most medicines that can be kept on shelves must not be exposed to temperatures 




 medicines.[8,9] Similarly, temperature-controlled medicines must be handled carefully to 
avoid decomposition or degradation caused by excessive heat.[10] 
The operational regulations of the system for private pharmaceutical facilities 
and products in Saudi Arabia contain several requirements for good storage and 
distribution of medicines.[11] According to this system, community pharmacies must 
have good air-conditioning systems that keep the temperature at ≤  25 °C and a 
thermometer for monitoring the temperature. Pharmacies must also have refrigerators 
with thermometers, and medicines must be kept away from sunlight. Floors and paints 
must be of materials that can be easily washed and cleaned. In addition, drug storage 
facilities must be equipped with automatic temperature recording systems that keep 
records for at least one year. 
However, the criteria and quality of inspection and monitoring of the community 
pharmacies by the regulatory authorities may not be efficient. For example, one can 
easily buy prescription-only medicines, such as antibiotics, without a prescription 
despite the strict regulations.[7,12] 
 
Objectives 
This study explored the extent to which community pharmacies in Riyadh 
complied with the local regulations for keeping medicines until they are sold. It also 
explored the opinions of community pharmacists about the quality of medicines and 






 Methods  
This study was approved by the Ethical Committee of Kanazawa University and 
the Saudi Food and Drug Authority (SFDA). 
 
Selection of Pharmacies 
 A list of all registered community pharmacies in Riyadh was obtained from the 
Saudi Ministry of Health (MOH) in August 2012 (1531 pharmacies). The calculated 
sample size of pharmacies was 181 according to the following formula: 
𝒏 = 𝒛𝟐𝑵(𝟏 − 𝒑) (𝒛𝟐𝒑(𝟏 − 𝒑) +⁄ 𝝃𝟐𝒑𝟐(𝑵− 𝟏)) 
where n is the required sample size; z is the reliability coefficient (equals1.96 at 95% 
confidence level); N is the population size; p is the probability of favorable outcome 
(set as 0.5); and ξ is set as 0.2 for the purpose of this study. 
After all pharmacies were coded, the list was scrambled and 181+45 pharmacies 
were randomly selected from the list with MS Excel 2010 (Microsoft Co., USA). The 
additional 45 pharmacies were used as a reserve for an estimated dropout rate of 25% 
that may occur when a pharmacy is closed on the second visit, the pharmacy is out of 
business, or the pharmacy refuses to cooperate in the survey. The survey included 68 
districts out of the 114 districts of Riyadh. The surveyed districts are sown in Annexes 
2.1 and 2.2 
 
Study Materials 
The survey was conducted using a structured interview with the pharmacist in 




 first form was a questionnaire while the second and third forms were used for inspection 
and observation purposes, respectively (Annexes 2.3‒2.5).  
Validity of the method was assessed on a sample of 33 pharmacies, not included 




Thirty-four, fourth-year pharmacy students from King Saud University in 
Riyadh conducted the interviews between November 2 and November 23, 2012, after 
having attended a workshop followed by field training for a period of one week 
accompanied by the investigator. In-field follow-up and necessary support were 
provided by the investigator and one of the co-investigators. The training and survey 
schedule can be found in Annex 2.6. 
The workshop started with an explanation of the survey objectives and a detailed 
presentation of the interview forms. It was followed by a discussion, where student 
questions were answered. The necessary communication skills were reviewed in brief 
since all students had already passed a course related to those skills. 
The workshop was followed by a rehearsal of the interview, where all students 
played the role of the interviewer while the investigator played the role of the 
pharmacist. Notes were taken about each conversation and each student with a 






 Results  
The final sample included 139 chain and 42 independent pharmacies, where a 
chain pharmacy belongs to a group of more than 3 pharmacies.[13] Twenty-one 
pharmacies were replaced because they were either closed on the second visit, out of 
business, or non-cooperative. The pharmacists in charge were all non-Saudi males and 
the summary of their background characteristics is shown in Table 2.1. 
 
Characteristicsa Value 
 Mean (years) Range 
Age 32 23‒55 
Total experience in community 
pharmacies 8.2 1‒28 
Experience in community pharmacies  
in Saudi Arabia 5.3 0.25‒25 
 Frequency 
(n = 181) % 
Qualification  
     B.Sc 
     Pharm.D 
     M.Sc 












     Egypt 
     Yemen 
     Jordan 
     India 
     Sudan 
     Syria 
     Palestine 




















     Manager 







a All were males. 
 





 About 15% of the pharmacists said that they had not been informed about the 
system of community pharmacy practice in Saudi Arabia. Surprisingly, a significant 
percentage of pharmacists who knew the system gave wrong answers to simple 
questions related to the system. Table 2.2 summarizes the pharmacists’ answers to such 
questions. 
All pharmacists reported that they always receive the supply of medicines either 
directly from an official distributor or from a central store that belongs to the owner, or 
both. However, one independent pharmacy reported purchasing some medicines from a 
subagent. Nearly 56% of the pharmacists reported that they sometimes rejected some 
supplies of medicines because the temperature of the shipments may have exceeded 
25 °C or because the packaging of the medicines was not intact upon receipt. When 
asked about the official distributors’ facilities, 16% of the pharmacists said that the 
distributors’ stores were substandard and 22% believed that the vehicles that were 
delivering the supply to the pharmacies were not suitable. In addition, 8% reported that 
they found some counterfeit products in their pharmacies and 46% reported that they 
had sometimes been contacted by illegal sellers offering known medicine brands at low 
prices. A significant percentage of the pharmacists reported that they found 
physicochemical changes in some of the medicines in their pharmacies; 16% noticed 
discoloration of some liquid medicines while 18.8% noticed wetting or solidification of 
powdered medicines. Sixty-seven percent of the pharmacists reported that they received 
complaints from their clients about subtherapeutic effects of some medicines. Only 64% 
said that they received memos from the drug regulatory authorities warning them of 




 Aspects Frequency n = 181 (%) 
Were you informed about the community pharmacy 
regulations in Saudi Arabia? 
     Yes 




Are you requested to complete a certain number of 
continuing education hours every year? 
     Yes, 60 hoursa 
     Yes, incorrect number of hours 
     Not required 






Is it allowed to give free samples of over-the-counter 
medicines to clients? 
     Yes 
     Noa 





Except antibiotics, is it allowed to sell medicines by 
individual strips? 
     Yesa 
     No 





Correct answers about some medicines that can be sold 
without a prescription 
     Mild cough preparations  
     Topical disinfectants  
     Multivitamins 
     Topical burn preparations 







Correct answers about some medicines that cannot be sold 
without a prescription 
     Antihypertensive drugs  
     Mild oral antibiotics 
     Strong oral antibiotics 






a. The correct answer. 
 






 Aspects Frequency n = 181 (%) 
How often is the pharmacy temperature kept at ≤ 25 °C during working hours in 
hot seasons? 
     100% 
     91‒99% 
     81‒90% 
     ≤ 80% 







How often is the pharmacy temperature kept at ≤ 25 °C after working hours in 
hot seasons? 
     100% 
     91‒99% 
     81‒90% 
     ≤ 80% 







How often is the supply delivered to the pharmacy at a temperature of ≤ 25 °C 
in hot seasons? 
     100% 
     91‒99% 
     81‒90% 
     ≤ 80% 







How often is the supply received in intact packaging? 
     100% 
     91‒99% 
     81‒90% 
     ≤ 80% 







To what extent do you believe that the medicines in this pharmacy contain the 
correct amount of active ingredients? 
     100% 
     91‒99% 
     81‒90% 
     ≤ 80% 








To what extent do you believe that Riyadh pharmacies adhere to optimal 
storage conditions?  
     100% 
     91‒99% 
     81‒90% 
     ≤ 80% 







How often is the pharmacy inspected by the pharmacy regulatory authorities? 
     Every 1‒6 months 
     Every 7‒12 months 
     Every 1‒2 years 






The pharmacist noticed broken capsules or tablets inside packaged products in 
the pharmacy  53 (29.3) 
The pharmacist noticed discoloration of some liquid medicines in the pharmacy  29 (16.0) 
The pharmacist noticed wetting or solidification of powdered medicines in the 
pharmacy  34 (18.8) 
Electricity blackout occurred during summer and pharmacy temperature raised 
above 25 °C 71 (39.2)
a 
a. Infrequent and lasts for 15‒180 minutes. 
 
Table 2.3.   Pharmacists’ opinions on the adherence of their pharmacies and 





 opinions about the compliance of their pharmacies as well as their drug distributors with 
the local regulations. 
In all pharmacies, excess medicines were stored in a small room inside each 
pharmacy. The inspection revealed serious problems regarding the temperature control 
in the pharmacies and in their refrigerators. Generally, the degree of cleanliness and 
neatness of pharmacies was considered acceptable since no serious breach was found. 
The recordings of inspections and observations made in each pharmacy are summarized 
in Table 2.4. 
Various scoring systems were used in different studies concerned with the 
quality of pharmacies for a variety of statistical analyses.[14,15] In this study, however, 
when scores were added to key observations, no significant differences were found 
between the means of various independent factors, for example, chain vs. independent 
pharmacies, managers vs. staff, pharmacist informed about the regulations in Saudi 
Arabia vs. those not informed, and pharmacists aware of the continuing education 
requirements vs. those who were unaware. The analysis of variance is not possible 
within nationality and qualification groups because the number of candidates in some of 
these groups was very small compared to others. Also, no correlation is found between 

















Elements Frequency n = 181 (%) 
Availability of an alternative power supply that covers the air-
conditioning and refrigerator 
10 (5.5) 
Availability of an additional air-conditioner 147 (81.2) 
Availability of a thermometer to measure pharmacy temperature 157 (86.7) 
Pharmacy thermometer reading was ≤ 25 °Ca n = 157 
143 (91.1) 
Availability of a refrigerator 179 (98.9) 
Availability of a thermometer in the refrigerator n = 179 
167 (93.3) 
Refrigerator thermometer reading was 3‒8 °Cb n = 167 
111 (66.5) 
Walls behind medicine shelves were not struck by direct 
sunlight from the outside 
136 (75.1) 
Walls behind medicine shelves were not hot or warm 173 (95.6) 
All medicines were not exposed to direct sunlight  160 (88.4) 
Availability of at least 1 comprehensive drug information 
reference 
37 (20.4) 
Availability of a copy of the local regulations for community 
pharmacy practice 
55 (30.4) 
Free medicine samples were not seen 176 (97.2) 
Medicine advertisement was not seen 153 (84.5) 
There was a sign that states that prescription drugs cannot be 
sold without a prescription 
158 (87.3) 
Shelves were cleanc 128 (70.7) 
Walls were cleanc 135 (74.6) 
Floor was cleanc 142 (78.5) 
Floor was smooth/washable 181 (100) 
Pharmacy was neatly organized (medicines were organized in 
shelves, shelves were organized in space, and pharmacy was not 
overcrowded with products) 
147 (81.2) 
a. Readings as high as 30 °C were observed in some pharmacies. 
b. Readings as low as ‒10 and as high as 20 °C were observed in some pharmacies. 
c. Free of dust, dirt, insects, or spider webs. 
 





 Discussion  
 The findings of this study suggest that there were some deficiencies in the 
storage of medicines in community pharmacies in Riyadh and probably in the delivery 
vehicles, especially during hot seasons. This may, at least partly, explain the existence 
of substandard levels of amoxicillin in Riyadh pharmacies.[7] Even basic thermometers 
were not available in about 13% of pharmacies, and in about 9% of the pharmacies 
equipped with thermometers, the reading exceeded the 25 °C threshold. About 19% of 
pharmacies lacked a spare air-conditioner, making the quality of medicines questionable 
if the only available air-conditioner fails to operate optimally during summer. What is 
worse, some pharmacists reported that the air-conditioners may not have been kept 
running after working hours in hot seasons. 
In addition, about 7% of refrigerators lacked thermometers, and in about 33% of 
refrigerators the temperatures were outside the accepted range. In about 25% of the 
pharmacies some walls behind medicine shelves were struck by direct sunlight from the 
outer side, and in about 4% of those pharmacies the walls felt warm. 
The local regulations must be updated accordingly to ensure the best storage and 
distribution conditions for the medicines. Such detailed conditions and specifications 
may be obtained from the WHO.[16,17] The existence of an alternative power supply that 
covers the air-conditioning and refrigerators might be necessary in Riyadh although 
electricity blackouts are infrequent. However, if the durations of blackouts are enough 
to raise the temperature inside the pharmacy or the refrigerator above the allowed limits, 
then at least the refrigerator and one air-conditioning unit must be linked to an 




 A significant percentage of pharmacists were unaware of the basic regulations relating 
to community pharmacy practice. The striking issue is that having knowledge about the 
regulations had no impact on the quality of storage in the pharmacies. This may explain 
the absence of any correlation between age or experience and the general score achieved. 
This also explains the lack of any significant differences between various grouping 
factors relative to the mean scores. 
Stricter, periodic monitoring and inspection by the authorities is highly 
recommended. It is suggested that all pharmacy owners must add spare air-conditioners 
as a prerequisite for licensing the pharmacies. Each pharmacy must be equipped with a 
room thermometer and refrigerator thermometer that keeps a record of temperature 
variation during the day. In addition, the pharmacy location must be in a position where 
its walls are not struck by direct sunlight from the outer side, or at least such walls must 
be adequately insulated. Medicine shelves must not be placed near the entrance or any 
location exposed to direct sunlight. Distributors’ storage and delivery facilities must 
also be strictly monitored. 
Finally, the continuing education program for community pharmacists must be 
closely monitored and supervised by the authorities. It is also recommended that passing 
an annual test about good pharmacy practice (GPP) should be a prerequisite for 





 Conclusions  
 The quality of on-shelf medicines sold in community pharmacies in Riyadh may 
be questionable during hot seasons. Meanwhile, refrigerated medicines may not meet 
the quality standards throughout the entire storage time. More assertive measures and 
stricter monitoring of the adherence of the community pharmacies to good practice and 
good storage regulations are highly recommended. Community pharmacists’ continuing 
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Annex 2.1.  Maps 




   





















1 1092 Al Nasiriyya
2 1000 Al Muaizliya
3 357 Al Uraija
4 121 Salahuddin
5 1417 Dharhrat Laban
6 1415 Dharhrat Laban
7 1403 Dharhrat Laban
8 203 Al Badi'ah
9 1382 Dirab
10 1428 Tuwaig
11 126 Al Badi'ah
12 946 Al Mursalat
13 277 Al Hamra
14 68 Al Quds
15 282 Al Hamra
16 94 Al Mughrizat
17 285 Al Hamra
18 1473 Qurtuba
19 1478 Qurtuba
20 691 Al Shuhada
21 494 Al Rayyan
22 516 Al Salam
23 515 Al Salam
24 491 Al Rayyan
25 194 Al Badi'ah
26 553 Al Sulaimania
27 597 Al Suwaidi
28 772 Al Uraija
29 784 Al Uraija
30 782 Al Uraija
31 728 Al Uraija
32 790 Al Uraija
33 748 Al Uraija
34 737 Al Uraija
35 459 Al Rawda
36 395 Al Rabwa
37 1240 Al Nafl
38 1237 Al Nafl
39 407 Al Rabi
40 735 Al Uraija
41 732 Al Uraija
42 745 Al Uraija
43 144 Ishbilia
44 1330 Al Yarmmouk
45 154 Ishbilia




47 1252 Al Nahda
48 964 Al Masif
49 860 Al Ulaya
50 933 Al Muhammadiya
51 937 Al Muhammadiya
52 843 Al Ulaya
53 847 Al Ulaya
54 849 Al Ulaya
55 859 Al Ulaya
56 756 Al Uraija
57 215 Al Badi'ah
58 178 Al Badi'ah
59 754 Al Uraija
60 742 Al Uraija
61 811 Al Azizia
62 166 Al Iskan
63 507 Al Zahra
64 1058 King Fahd
65 1024 Al Malaz
66 977 Al Masif
67 1470 Ghurnata
68 276 Al Hamra
69 367 Al Dira
70 303 Al Khuzama
71 169 Al Andalus
72 871 Al Ulaya
73 418 Al Rawabi
74 842 Al Ulaya
75 225 Al Bat'ha
76 876 Al Ulaya
77 711 Al Sahafa
78 408 Al Rabi
79 898 Al Ghadir
80 372 Al Raid
81 257 Al Taawun
82 1440 Irqa
83 362 Al Diriya
84 1109 Al Nuzha
85 702 Al Sahafa
86 404 Al Rabi
87 161 Al Izdihar
88 1138 Al Naseem
89 1140 Al Naseem
90 693 Al Salihia
91 1147 Al Naseem
92 1170 Al Naseem








93 1126 Al Naseem
94 1146 Al Naseem
95 1171 Al Naseem
96 1040 Al Malaz
97 1017 Al Malaz
98 1049 King Fahd
99 978 Al Masif
100 1005 Al Malaz
101 984 Al Masif
102 218 Al Badi'ah
103 183 Al Badi'ah
104 347 Al Dar Al Baida
105 586 Al Suwaidi
106 3 Al Mansoura
107 672 Al Shifa
108 645 Al Shifa
109 641 Al Shifa
110 620 Al Suwaidi
111 659 Al Shifa
112 274 Al Hamra
113 1250 Al Nahda
114 134 Ishbilia
115 1244 Al Nahda
116 136 Ishbilia
117 1270 Al Nahda
118 1242 Al Nahda
119 26 Al Yamama
120 100 Al Manakh
121 422 Al Rawabi
122 1068 King Faisal
123 991 Al Mathar
124 539 Al Sulaimania
125 489 Al Rayyan
126 447 Al Rawda
127 48 Al Sulayy
128 485 Al Rawda
129 104 Al Manar
130 1076 King Faisal
131 309 Al Khaleej
132 146 Ishbilia
133 1210 Al Naseem
134 1201 Al Naseem
135 1211 Al Naseem
136 503 Al Rayyan
137 313 Al Khaleej




139 314 Al Khaleej
140 334 Al Khaleej
141 1443 Ulaisha
142 584 Al Suwaidi
143 622 Al Suwaidi
144 596 Al Suwaidi
145 181 Al Badi'ah
146 678 Al Shumaisi
147 680 Al Shumaisi
148 397 Al Rabwa
149 524 Al Salam
150 521 Al Salam
151 426 Al Rawabi
152 386 Al Rabwa
153 1285 Al Wuroud
154 1335 Al Yarmmouk
155 1323 Al Yarmmouk
156 1318 Al Yarmmouk
157 1116 Al Nuzha
158 1294 Al Wuroud
159 1117 Al Nuzha
160 1317 Al Yasameen
161 704 Al Sahafa
162 1282 Al Wuroud
163 46 Al Sulayy
164 11 Al Mansoura
165 9 Al Mansoura
166 1518 Manfouha
167 27 Al Yamama
168 957 Al Margab










179 1127 Al Naseem
180 1313 Al Washm
181 7 Al Mansoura



















































































































Annex 2.6  Training and survey schedule 
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